Efficacy and Safety Study of IBI-10090 in Patients Undergoing Cataract Surgery
NCT01048593
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class
Stopped
Study was terminated in order to examine study data.
Conditions
Inflammatory Reaction Due to Ocular Lens Prosthesis
Interventions
DRUG:
IBI-10090
Sponsor
ICON Bioscience Inc